
CSF biomarkers β-amyloid, tau proteins and a-synuclein in the differential diagnosis of Parkinson-plus syndromes
Keywords: Aβ42; beta-amyloid; AD; Alzheimer's disease; ANCOVA; analysis of covariance; ANOVA; analysis of variance; a-syn; a-synuclein; CBD; Corticobasal degeneration; CBS; corticobasal syndrome; CBS-AD; corticobasal syndrome with underlying AD pathology; CBS-non-